@article{oai:tsukuba.repo.nii.ac.jp:00055263,
 author = {森, 隆浩 and MORI, Takahiro and Hasegawa, Shinya and Shiraishi, Atsushi and Yaegashi, Makito and Hosokawa, Naoto and Morimoto, Konosuke},
 issue = {15},
 journal = {Journal of Comparative Effectiveness Research},
 month = {Nov},
 note = {Aim: To compare hospital mortality in patients with aspiration-associated pneumonia treated with ceftriaxone (CTRX) and in those treated with ampicillin/sulbactam (ABPC/SBT). Methods: From a Japanese multicentre observational study cohort of patients with pneumonia, those diagnosed with pneumonia and having at least one aspiration-related risk factor were selected. Propensity score-matching analysis was used to balance baseline characteristics of the participants and compare hospital mortality of patients treated with CTRX and those treated with ABPC/SBT. Results: Hospital mortality did not significantly differ between patients treated with CTRX and those treated with ABPC/SBT (6.6 vs 10.7%, risk difference -4.0, 95% CI [-9.4, 1.3]; p = 0.143). Conclusion: Further studies are needed to compare CTRX and ABPC/SBT treatments in patients with aspiration-associated pneumonia.},
 pages = {1275--1284},
 title = {Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults},
 volume = {8},
 year = {2019},
 yomi = {モリ, タカヒロ}
}